Motor neuron disease mortality rates in New Zealand 1992–2013

References

• Mandrioli J, Faglioni P, Nichelli P, Sola P. Amyotrophic lateral sclerosis: prognostic indicators of survival. Amyotroph Lateral Scler. 2006;7:211–20.
   PubMed Web of Science ®Google Scholar
• Seljeseth YM, Vollset SE, Tysnes OB. Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology. 2000;55:1262–6.
   PubMed Web of Science ®Google Scholar
• Gunnarsson LG, Lindberg G, Soderfelt B, Axelson O. The mortality of motor neuron disease in Sweden. Arch Neurol. 1990;47:42–6.
   PubMed Web of Science ®Google Scholar
• Baker PC. Incidence of motor neuron disease in Hawke's Bay and Gisborne/East Coast. N Z Med J. 2015;128:79–80.
   PubMed Web of Science ®Google Scholar
• Dayal V, Rosemergy I, Turnbull J. Motor neuron disease in the greater Wellington region: an observational study. N Z Med J. 2015;128:29–34.
   PubMed Web of Science ®Google Scholar
• Murphy M, Quinn S, Young J, Parkin P, Taylor B. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology. 2008;71:1889–95.
   PubMed Web of Science ®Google Scholar
• Chio A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41:118–30.
   PubMed Web of Science ®Google Scholar
• Marin B, Boumediene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46:57–74.
   PubMed Web of Science ®Google Scholar
• Kiddle E. Cluster Investigation into Motor Neuron Disease Nelson. Nelson: Nelson Marlborough Distrct Health Board; 2005.
   Google Scholar
• Shaw I. Motor neuron disease – a methyl bromide exposure cluster points to a causal mechanism. Hum Exp Toxicol. 2010;29:241–2.
   PubMed Web of Science ®Google Scholar
• Scotter EL. Motor neuron disease: bringing New Zealand patients onto the world stage. N Z Med J. 2015;128:12–4.
   PubMed Web of Science ®Google Scholar
• Corcia P, Pradat PF, Salachas F, Bruneteau G, Forestier N, Seilhean D, et al. Causes of death in a post-mortem series of ALS patients. Amyotroph Lateral Scler. 2008;9:59–62.
   PubMed Web of Science ®Google Scholar
• Statistics New Zealand Tatauranga Aotearoa [Internet]. National population projections, by age and sex, 2016(base)-2068. 2016. Available at: http://nzdotstat.stats.govt.nz/wbos/Index.aspx?DataSetCode=TABLECODE7542#. Accessed January 10, 2018.
   Google Scholar
• Eurostat. Revision of the European standard population — report of Eurostat's task force. Luxembourg: European Commission; 2013.
   Google Scholar
• Statistics New Zealand Tatauranga Aotearoa [Internet].2013 Census QuickStats about culture and identity. 2013. Available at: http://www.stats.govt.nz.
   Google Scholar
• Scotter EL, Smyth L, Bailey JA, Wong CH, de Majo M, Vance CA, et al. C9ORF72 and UBQLN2 mutations are causes of amyotrophic lateral sclerosis in New Zealand: a genetic and pathologic study using banked human brain tissue. Neurobiol Aging. 2017;49:214 e1–e5.
   PubMed Web of Science ®Google Scholar
• Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012;11:323–30.
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9:617–28.
   PubMed Web of Science ®Google Scholar
• Couratier P, Corcia P, Lautrette G, Nicol M, Preux PM, Marin B. Epidemiology of amyotrophic lateral sclerosis: a review of literature. Rev Neurol (Paris). 2016;172:37–45.
   PubMed Web of Science ®Google Scholar
• Scotter EL, Chen HJ, Shaw CE. TDP-43 proteinopathy and ALS: insights into disease mechanisms and therapeutic targets. Neurotherapeutics. 2015;12:352–63.
   PubMed Web of Science ®Google Scholar
• Leone M, Chandra V, Schoenberg BS. Motor neuron disease in the United States, 1971 and 1973–1978: patterns of mortality and associated conditions at the time of death. Neurology. 1987;37:1339–43.
   PubMed Web of Science ®Google Scholar
• Noonan CW, White MC, Thurman D, Wong LY. Temporal and geographic variation in United States motor neuron disease mortality, 1969–1998. Neurology. 2005;64:1215–21.
   PubMed Web of Science ®Google Scholar
• Valenzuela D, Zitko P, Lillo P. Amyotrophic lateral sclerosis mortality rates in Chile: a population based study (1994–2010). Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:372–7.
   PubMed Web of Science ®Google Scholar
• Chancellor AM, Warlow CP. Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. J Neurol Neurosurg Psychiatry. 1992;55:1106–15.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
   PubMed Web of Science ®Google Scholar
• Worms PM. The epidemiology of motor neuron diseases: a review of recent studies. J Neurol Sci. 2001;191:3–9.
   PubMed Web of Science ®Google Scholar
• McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gender Medicine. 2010;7:557–70.
   PubMed Web of Science ®Google Scholar
• Chancellor AM, Hendry A, Caird FI, Warlow CP, Weir AI. Motor neuron disease: a disease of old age. Scott Med J. 1993;38:178–82.
   PubMed Web of Science ®Google Scholar
• Manjaly ZR, Scott KM, Abhinav K, Wijesekera L, Ganesalingam J, Goldstein LH, et al. The sex ratio in amyotrophic lateral sclerosis: a population based study. Amyotroph Lateral Scler. 2010;11:439–42.
   PubMed Web of Science ®Google Scholar
• Dean G, Elian M. Motor neuron disease and multiple sclerosis mortality in Australia, New Zealand, and South Africa compared with England and Wales. J Neurol Neurosurg Psychiatry. 1993;56:633–7.
   PubMed Web of Science ®Google Scholar
• Statistics New Zealand Tatauranga Aotearoa [Internet]. Life Expectancy at Birth, Māori Ethnic Group Population by Sex (Annual-Dec). 2017. Available at: http://www.stats.govt.nz/infoshare/.
   Google Scholar
• Ellison-Loschmann L, Pearce N. Improving access to health care among New Zealand's Maori population. Am J Public Health. 2006;96:612–7.
   PubMed Web of Science ®Google Scholar
• Statistics New Zealand Tatauranga Aotearoa [Internet]. Estimated Resident Population (Mean Quarter Ended) by Sex (1991+) (Qrtly-Mar/Jun/Sep/Dec). 2017. Available at: http://www.stats.govt.nz/infoshare/.
   Google Scholar
• Rooney JPK, Brayne C, Tobin K, Logroscino G, Glymour MM, Hardiman O. Benefits, pitfalls, and future design of population-based registers in neurodegenerative disease. Neurology. 2017;88:2321–9.
   PubMed Web of Science ®Google Scholar
• Gordon PH, Artaud F, Aouba A, Laurent F, Meininger V, Elbaz A. Changing mortality for motor neuron disease in France (1968–2007): an age-period-cohort analysis. Eur J Epidemiol. 2011;26:729–37.
   PubMed Web of Science ®Google Scholar
• Okamoto K, Kobashi G, Washio M, Sasaki S, Yokoyama T, Miyake Y, et al. Descriptive epidemiology of amyotrophic lateral sclerosis in Japan, 1995–2001. J Epidemiol. 2005;15:20–3.
   PubMed Web of Science ®Google Scholar
• Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology. 2009;72:1640–5.
   PubMed Web of Science ®Google Scholar
• Veiga-Cabo J, Almazan-Isla J, Sendra-Gutierrez JM, de Pedro-Cuesta J. Differential features of motor neuron disease mortality in Spain. Int J Epidemiol. 1997;26:1024–32.
   PubMed Web of Science ®Google Scholar
• Day TG, Scott M, Perring R, Doyle P. Motor neuron disease mortality in Great Britain continues to rise: examination of mortality rates 1975–2004. Amyotroph Lateral Scler. 2007;8:337–42.
   PubMed Web of Science ®Google Scholar
• Maasilta P, Jokelainen M, Loytonen M, Sabel CE, Gatrell AC. Mortality from amyotrophic lateral sclerosis in Finland, 1986–1995. Acta Neurol Scand. 2001;104:232–5.
   PubMed Web of Science ®Google Scholar